Target intelligence / Profile preview

Caffeic acid 3-O-methyltransferase (COMT) (COMT)

Target
COMT
Molecular classification
Enzyme, Methyltransferase, O-methyltransferase
01

Overview

Caffeic acid 3-O-methyltransferase (COMT) is a key enzyme in the phenylpropanoid pathway, primarily responsible for the biosynthesis of lignin in plants. It catalyzes the O-methylation of caffeic acid and 5-hydroxyferulic acid to produce ferulic acid and sinapic acid, respectively, using S-adenosyl-L-methionine as the methyl donor (UniProt: P46484). This enzymatic activity is essential for the production of syringyl (S) lignin subunits, which provide structural integrity and mechanical strength to plant cell walls (PubMed: 20566714). While COMT is not a therapeutic target for human diseases, it is a major target in agricultural biotechnology and the biofuel industry. Genetic modulation of COMT is used to reduce lignin content or alter its composition to improve the processing efficiency of biomass for biofuels and enhance the nutritional quality of forage crops (ScienceDirect: S0960-8524(11)00344-1). Potential challenges in targeting COMT include unintended effects on plant growth, such as increased susceptibility to lodging or altered resistance to environmental stressors. Research into COMT inhibitors is primarily focused on understanding plant metabolism and optimizing biomass for industrial applications.

Other names
Caffeate O-methyltransferase5-hydroxyferulic acid O-methyltransferaseCaffeic acid 3-O-methyltransferaseS-adenosyl-L-methionine:caffeic acid 3-O-methyltransferase
02

Mechanism of action

Catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to the 3-hydroxyl group of caffeic acid or the 5-hydroxyl group of 5-hydroxyferulic acid.

03

Biological functions

Lignin biosynthesisPhenylpropanoid metabolismSecondary metabolismCell wall organization
04

Safety considerations

Reduced plant structural integrityIncreased susceptibility to lodgingAltered plant defense responses
05

Biomarkers

Lignin S/G ratioSyringyl lignin content

Beyond the preview

Go deeper on Caffeic acid 3-O-methyltransferase (COMT) (COMT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caffeic acid 3-O-methyltransferase (COMT) (COMT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call